- cafead   Sep 13, 2020 at 10:33: PM
via Gilead on Sunday reached a deal to buy Immunomedics for approximately $21 billion, agreeing to pay more than double the New Jersey drugmaker's market value to gain access to its recently approved breast cancer medicine.
article source
article source